Guerbet is a human-scale company that aims to become a new global leader in medical imaging.
Pioneer in contrast media with more than 90 years’ experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors. Guerbet offers a comprehensive range of imaging products, solutions and services for Diagnostic Imaging (CT/Cath Lab examinations, Magnetic Resonance Imaging (MRI)) and Interventional Imaging (Contrast agents and medical devices).
More than 60,000 health professionals rely on Guerbet’s contrast agents. Advancing in innovation solutions, the diagnosis of major diseases (cardiovascular diseases, cancers, diseases of the central nervous system) and interventional radiology while reconciling efficacy and cost containment, are at the heart of Guerbet’s mission.
Passionate about its business, the company strive day in, day out to combine performance, quality and sustainable development.